Ubs Group Ag Pulse Biosciences, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 13,800 shares of PLSE stock, worth $243,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,800

Previous 5,570 147.76%

Holding current value

$243,984

Previous $62,000 290.32%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.83 - $21.83 $78,214 - $157,656	7,222 Added 129.66%	12,792 $224,000
Q2 2024 Aug 13, 2024	SELL	$6.69 - $14.54 $71,101 - $154,531	-10,628 Reduced 65.61%	5,570 $62,000
Q1 2024 May 13, 2024	SELL	$7.8 - $11.02 $19,211 - $27,142	-2,463 Reduced 13.2%	16,198 $141,000
Q4 2023 Feb 09, 2024	BUY	$3.85 - $12.84 $37,083 - $123,674	9,632 Added 106.68%	18,661 $228,000
Q3 2023 Nov 09, 2023	SELL	$4.03 - $8.73 $1,422 - $3,081	-353 Reduced 3.76%	9,029 $36,000
Q2 2023 Aug 11, 2023	BUY	$3.67 - $8.64 $34,431 - $81,060	9,382 New	9,382 $67,000
Q3 2022 Nov 10, 2022	SELL	$1.23 - $2.3 $864 - $1,616	-703 Reduced 87.55%	100 $0
Q2 2022 Aug 10, 2022	BUY	$1.48 - $4.28 $710 - $2,054	480 Added 148.61%	803 $1,000
Q1 2022 May 16, 2022	SELL	$4.21 - $14.79 $27,242 - $95,706	-6,471 Reduced 95.25%	323 $2,000
Q4 2021 Feb 14, 2022	BUY	$14.78 - $24.4 $100,415 - $165,773	6,794 New	6,794 $101,000
Q2 2021 Aug 13, 2021	SELL	$16.31 - $23.64 $53,235 - $77,160	-3,264 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$22.43 - $44.27 $87,454 - $172,608	-3,899 Reduced 54.43%	3,264 $77,000
Q4 2020 Feb 11, 2021	SELL	$11.66 - $24.5 $14,831 - $31,164	-1,272 Reduced 15.08%	7,163 $171,000
Q3 2020 Nov 12, 2020	SELL	$9.27 - $13.14 $39,536 - $56,042	-4,265 Reduced 33.58%	8,435 $99,000
Q2 2020 Jul 31, 2020	SELL	$6.23 - $13.09 $16,129 - $33,890	-2,589 Reduced 16.93%	12,700 $133,000
Q1 2020 May 01, 2020	BUY	$5.23 - $15.2 $2,170 - $6,308	415 Added 2.79%	15,289 $109,000
Q4 2019 Feb 14, 2020	BUY	$12.58 - $15.97 $19,914 - $25,280	1,583 Added 11.91%	14,874 $199,000
Q3 2019 Nov 14, 2019	BUY	$10.73 - $17.33 $61,407 - $99,179	5,723 Added 75.62%	13,291 $205,000
Q2 2019 Aug 14, 2019	SELL	$11.11 - $17.34 $31,785 - $49,609	-2,861 Reduced 27.43%	7,568 $100,000
Q1 2019 May 14, 2019	SELL	$11.69 - $19.44 $31,796 - $52,876	-2,720 Reduced 20.69%	10,429 $183,000
Q4 2018 Feb 14, 2019	SELL	$9.08 - $14.34 $41,450 - $65,462	-4,565 Reduced 25.77%	13,149 $151,000
Q3 2018 Nov 14, 2018	BUY	$12.83 - $16.45 $12,650 - $16,219	986 Added 5.89%	17,714 $251,000
Q2 2018 Aug 14, 2018	BUY	$14.04 - $20.28 $111,112 - $160,495	7,914 Added 89.79%	16,728 $253,000
Q1 2018 May 15, 2018	SELL	$12.67 - $24.69 $177 - $345	-14 Reduced 0.16%	8,814 $119,000
Q4 2017 Feb 14, 2018	SELL	$18.81 - $30.33 $67,678 - $109,127	-3,598 Reduced 28.96%	8,828 $208,000
Q3 2017 Nov 14, 2017	BUY	$10.26 - $24.97 $32,821 - $79,879	3,199 Added 34.67%	12,426 $231,000
Q2 2017 Aug 14, 2017	SELL	N/A	-16,559 Reduced 64.22%	9,227 $319,000
Q1 2017 Nov 14, 2017	BUY	N/A	25,786	25,786 $526,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

5.41M

Call Options Held

139K

Put Options Held

84.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $656M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account